In patients with secondary antiphospholipid syndrome (APS) associated with SLE, these antibodies may be directed against phosphatidylserine, prothrombin (PT), and annexin V. Their presence elevates the risk of thrombotic complications, especially when observed at higher frequencies and concentrations [38]. The gene discussed is F2; the disease is systemic lupus erythematosus.